C07D 233/86
Oxygen and sulfur atoms
Official title: Oxygen and sulfur atoms, e.g. thiohydantoin
C07D233/86 (Oxygen and sulfur atoms) appears on 189 US grants and 148 published applications in this corpus.
Search patents in C07D- Granted patents
- 189
- Published applications
- 148
- Assignees
- 125
- Inventors
- 515
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 6 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 2 |
| 2003 | 3 | 3 |
| 2004 | 7 | 9 |
| 2005 | 2 | 3 |
| 2006 | 1 | 4 |
| 2007 | 4 | 8 |
| 2008 | 1 | 4 |
| 2009 | 1 | 4 |
| 2010 | 5 | 7 |
| 2011 | 1 | 2 |
| 2012 | 5 | 6 |
| 2013 | 3 | 7 |
| 2014 | 5 | 10 |
| 2015 | 7 | 9 |
| 2016 | 3 | 8 |
| 2017 | 6 | 15 |
| 2018 | 11 | 12 |
| 2019 | 5 | 5 |
| 2020 | 5 | 10 |
| 2021 | 1 | 5 |
| 2022 | 4 | 2 |
| 2023 | 6 | 4 |
| 2024 | 2 | 4 |
| 2025 | 3 | 4 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polymeric disinfectants and uses thereof17 Feb 2026US 12,552,882 B2Technion Research & Development Foundation Limited
- Formulations of enzalutamide23 Dec 2025US 12,502,357 B2Astellas Pharma Inc.
- Formulations of enzalutamide21 Oct 2025US 12,447,128 B2Astellas Pharma Inc.
- Compounds and methods for the targeted degradation of androgen receptor27 May 2025US 12,312,316 B2Arvinas Operations, Inc.
- 4-[4,4-bis(4-bromophenyl)-5-oxo-2-thioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound31 Dec 2024US 12,180,169 B1King Faisal University
- Androgen receptor degraders for the treatment of castration-resistant prostate cancer and use thereof11 Jun 2026US 2026/0159485 A1Autotac Inc.
- Diarylhydantoin compounds30 Oct 2025US 2025/0333385 A1The Regents of the University of California
- Compounds and methods for the targeted degradation of androgen receptor10 Jul 2025US 2025/0223265 A1Arvinas Operations, Inc.
- Formulations of Enzalutamide20 Mar 2025US 2025/0090465 A1Astellas Pharma Inc.
- Formulations of Enzalutamide13 Feb 2025US 2025/0049721 A1Astellas Pharma Inc.
Most cited
By later US patents
- Androgenic directed compositions95US 5,656,651 ABiophysica, Inc. · 1997
- Phenylimidazolidines having antiandrogenic activity85US 5,411,981 ARoussel Uclaf · 1995
- Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents80US 5,208,250 AWarner-Lambert Company · 1993
- Optionally substituted phenylimidazolidines, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them70US 5,750,553 ARoussel Uclaf · 1998
- Herbicidal hydantoins66US 4,944,791 AShell Internationale Research Maatschappij B. V. · 1990